Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Cortex Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03257891
What this trial is testing

Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 25
Not applicableUnknownNCT02747355
What this trial is testing

Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors

Who this might be right for
Adrenal Cortex NeoplasmsAdrenal Cortex Diseases
Bnai Zion Medical Center 70
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT01096654
What this trial is testing

SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan.

Who this might be right for
Hyperaldosteronism
Radboud University Medical Center 200
Testing effectiveness (Phase 2)Looking for participantsNCT06756061
What this trial is testing

Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity

Who this might be right for
GVHD - Graft-Versus-Host DiseaseNeoplasmsHaematopoietic Stem Cell Transplantation
Byung-Sik Cho 88
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05563467
What this trial is testing

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

Who this might be right for
Adrenocortical Carcinoma
Maria Sklodowska-Curie National Research Institute of Oncology 24
Testing effectiveness (Phase 2)Study completedNCT02468193
What this trial is testing

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Who this might be right for
Cushing's SyndromeEctopic Corticotropin SyndromeAdrenal Adenoma+3 more
Novartis Pharmaceuticals 9
Not applicableEnded earlyNCT04447014
What this trial is testing

Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical CarcinomaAdrenocortical Cancer
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT00700414
What this trial is testing

International Pediatric Adrenocortical Tumor Registry

Who this might be right for
Adrenocortical Tumor
St. Jude Children's Research Hospital 9,999
Testing effectiveness (Phase 2)Study completedNCT00215202
What this trial is testing

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Who this might be right for
Nonresectable Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center 16
Not applicableNot Yet RecruitingNCT07700472
What this trial is testing

Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma

Who this might be right for
Primary AldosteronismAldosterone-Producing Adenoma
Chongqing Medical University 30
Testing effectiveness (Phase 2)Study completedNCT01514526
What this trial is testing

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group 17
Testing effectiveness (Phase 2)Study completedNCT01262235
What this trial is testing

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Who this might be right for
CancerNeuroendocrine TumorsNET+2 more
Arbutus Biopharma Corporation 68
Testing effectiveness (Phase 2)Study completedNCT02067143
What this trial is testing

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate

Who this might be right for
Untreated Philadelphia Positive Acute Lymphoblastic LeukemiaDe NovoSecondary+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 204
Testing effectiveness (Phase 2)Study completedNCT00624416
What this trial is testing

Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

Who this might be right for
Lipoma
Pennington Biomedical Research Center 10
Not applicableStudy completedNCT02015026
What this trial is testing

Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 67
Not applicableStudy completedNCT02324647
What this trial is testing

Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield

Who this might be right for
Adrenal IncidentalomaAdrenocortical Carcinoma
University Medical Center Groningen 807
Testing effectiveness (Phase 2)Looking for participantsNCT07378761
What this trial is testing

Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis

Who this might be right for
Immune-Mediated Cholestasis
University Hospital, Montpellier 94
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46
Next Page